LV5511A3 - Ú3H¾-imidazo-Ú5,1-a¾-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas panemiens - Google Patents

Ú3H¾-imidazo-Ú5,1-a¾-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas panemiens

Info

Publication number
LV5511A3
LV5511A3 LV930621A LV930621A LV5511A3 LV 5511 A3 LV5511 A3 LV 5511A3 LV 930621 A LV930621 A LV 930621A LV 930621 A LV930621 A LV 930621A LV 5511 A3 LV5511 A3 LV 5511A3
Authority
LV
Latvia
Prior art keywords
ú3h3⁄4
tetrazin
imidazo
derivative yield
derivative
Prior art date
Application number
LV930621A
Other languages
English (en)
Latvian (lv)
Inventor
Edward Lunt
Malcolm Francis Graham Stevens
Robert Stone
Kenneth Robert Haro Wooldridge
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of LV5511A3 publication Critical patent/LV5511A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
LV930621A 1981-08-24 1993-06-19 Ú3H¾-imidazo-Ú5,1-a¾-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas panemiens LV5511A3 (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8125791 1981-08-24
SU823482389A SU1447284A3 (ru) 1981-08-24 1982-08-23 Способ получени производного @ 3Н @ -имидазо- @ 5,1- @ -1,2,3,5-тетразин-4-она

Publications (1)

Publication Number Publication Date
LV5511A3 true LV5511A3 (lv) 1994-03-10

Family

ID=10524141

Family Applications (2)

Application Number Title Priority Date Filing Date
LV930621A LV5511A3 (lv) 1981-08-24 1993-06-19 Ú3H¾-imidazo-Ú5,1-a¾-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas panemiens
LV931303A LV5621A3 (lv) 1981-08-24 1993-12-03 [3H]-imidazo-[5,1-a]-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas metode

Family Applications After (1)

Application Number Title Priority Date Filing Date
LV931303A LV5621A3 (lv) 1981-08-24 1993-12-03 [3H]-imidazo-[5,1-a]-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas metode

Country Status (29)

Country Link
JP (1) JPS5843975A (enrdf_load_html_response)
KR (1) KR890000094B1 (enrdf_load_html_response)
AT (1) AT380256B (enrdf_load_html_response)
AU (1) AU571430B2 (enrdf_load_html_response)
BE (1) BE894175A (enrdf_load_html_response)
CA (1) CA1197247A (enrdf_load_html_response)
CH (1) CH655114A5 (enrdf_load_html_response)
DE (2) DE3231255A1 (enrdf_load_html_response)
DK (1) DK161147C (enrdf_load_html_response)
ES (1) ES515176A0 (enrdf_load_html_response)
FI (1) FI73434C (enrdf_load_html_response)
FR (1) FR2511679A1 (enrdf_load_html_response)
GB (1) GB2104522B (enrdf_load_html_response)
GE (1) GEP19960641B (enrdf_load_html_response)
GR (1) GR76863B (enrdf_load_html_response)
HU (1) HU186107B (enrdf_load_html_response)
IE (1) IE53408B1 (enrdf_load_html_response)
IL (1) IL66606A (enrdf_load_html_response)
IT (1) IT1152505B (enrdf_load_html_response)
LT (1) LT2436B (enrdf_load_html_response)
LU (1) LU84347A1 (enrdf_load_html_response)
LV (2) LV5511A3 (enrdf_load_html_response)
NL (2) NL192739C (enrdf_load_html_response)
NZ (1) NZ201668A (enrdf_load_html_response)
OA (1) OA07174A (enrdf_load_html_response)
SE (1) SE448543B (enrdf_load_html_response)
SU (1) SU1447284A3 (enrdf_load_html_response)
UA (1) UA5971A1 (enrdf_load_html_response)
ZA (1) ZA826120B (enrdf_load_html_response)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260291A (en) * 1981-08-24 1993-11-09 Cancer Research Campaign Technology Limited Tetrazine derivatives
GB2125402B (en) * 1982-08-17 1985-11-13 May & Baker Ltd New tetrazine derivatives
GR78688B (enrdf_load_html_response) * 1982-08-17 1984-09-27 May & Baker Ltd
US4517182A (en) * 1983-05-24 1985-05-14 Warner-Lambert Company 3-(Haloethyl)-4-oxopyrazolo-[5,1-d]-1,2,3,5-tetrazine-8-carboxamide composition
GB8616125D0 (en) * 1986-07-02 1986-08-06 May & Baker Ltd Compositions of matter
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
AU718268B2 (en) * 1995-09-25 2000-04-13 Sanofi-Aventis U.S. Llc 1,2,4-benzotriazine oxides formulations
US7615632B2 (en) 2003-12-30 2009-11-10 Chemagis Ltd. Crystalline forms of temozolomide
CA2594477C (en) 2005-01-21 2016-07-12 Astex Therapeutics Limited Pharmaceutical compounds
PE20080695A1 (es) 2006-04-27 2008-06-28 Banyu Pharma Co Ltd Derivados de dihidropirazolopirimidinona como inhibidores de quinasa weel
JP2008081492A (ja) 2006-08-31 2008-04-10 Banyu Pharmaceut Co Ltd オーロラａ選択的阻害作用を有する新規アミノピリジン誘導体
US8883790B2 (en) 2006-10-12 2014-11-11 Astex Therapeutics Limited Pharmaceutical combinations
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
WO2009054332A1 (ja) 2007-10-23 2009-04-30 Banyu Pharmaceutical Co., Ltd. ピリドン置換ジヒドロピラゾロピリミジノン誘導体
PE20091101A1 (es) * 2007-12-18 2009-07-26 Pharminox Ltd AMIDAS DE ACIDO 3-SUBSTITUIDO-4-OXO-3,4-DIHIDRO-IMIDAZO[5,1-d] [1,2,3,5-TETRACINA-8-CARBOXILICO Y SU EMPLEO
US8716471B2 (en) * 2008-11-24 2014-05-06 Reliance Life Sciences Pvt. Ltd. Process for the preparation of tetrazine derivatives
WO2010101734A1 (en) 2009-03-06 2010-09-10 Merck Sharp & Dohme Corp. Combination cancer therapy with an akt inhibitor and other anticancer agents
CA2763766A1 (en) 2009-06-23 2010-12-29 Pharminox Limited 3-substituted-8-substituted-3h-imidazo[5,1-d][1,2,3,5-tetrazin-4-one compounds and their use
RU2462466C1 (ru) * 2011-06-24 2012-09-27 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Замещенные азоло[1,2,4,5]тетразины - ингибиторы актинобактериальных серин-треониновых протеинкиназ
US20140271657A1 (en) 2011-10-12 2014-09-18 Children's Medical Center Corporation Combinatorial compositions and methods of treating hemoglobinopathies
CN120661674A (zh) 2016-03-15 2025-09-19 奥莱松基因组股份有限公司 用于治疗实体瘤的lsd1抑制剂的组合
KR101847342B1 (ko) * 2017-05-08 2018-04-11 (주)센텍코리아 웨어러블 체지방 연소량 측정기

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2932305A1 (de) * 1979-08-09 1981-02-26 Basf Ag Azolo- eckige klammer auf 5,1-d eckige klammer zu - eckige klammer auf 1,2,3,5 eckige klammer zu -tetrazin-4-one und verfahren zur herstellung dieser verbindungen

Also Published As

Publication number Publication date
ES8400438A1 (es) 1983-11-01
FI822921A0 (fi) 1982-08-23
NL192739B (nl) 1997-09-01
HU186107B (en) 1985-06-28
JPS5843975A (ja) 1983-03-14
DK161147B (da) 1991-06-03
IE822026L (en) 1983-02-24
BE894175A (fr) 1983-02-23
SE8204817L (sv) 1983-02-25
KR840001175A (ko) 1984-03-28
FR2511679B1 (enrdf_load_html_response) 1985-02-01
NL192739C (nl) 1998-01-06
FR2511679A1 (fr) 1983-02-25
KR890000094B1 (ko) 1989-03-07
IT1152505B (it) 1987-01-07
IL66606A0 (en) 1982-12-31
UA5971A1 (uk) 1994-12-29
DK161147C (da) 1991-11-18
NL8203286A (nl) 1983-03-16
FI822921L (fi) 1983-02-25
DE19975037I2 (de) 2001-06-13
DE3231255A1 (de) 1983-03-03
IE53408B1 (en) 1988-11-09
ATA319182A (de) 1985-09-15
NZ201668A (en) 1985-08-16
NL990010I2 (nl) 1999-09-01
LV5621A3 (lv) 1994-05-10
GB2104522A (en) 1983-03-09
IL66606A (en) 1987-07-31
DK377882A (da) 1983-02-25
LU84347A1 (fr) 1983-06-07
LT2436B (lt) 1994-02-15
IT8222938A0 (it) 1982-08-23
AU571430B2 (en) 1988-04-21
SE8204817D0 (sv) 1982-08-23
GB2104522B (en) 1985-06-12
OA07174A (fr) 1984-04-30
CH655114A5 (fr) 1986-03-27
FI73434B (fi) 1987-06-30
CA1197247A (fr) 1985-11-26
NL990010I1 (nl) 1999-07-01
GR76863B (enrdf_load_html_response) 1984-09-04
ZA826120B (en) 1983-07-27
FI73434C (fi) 1987-10-09
JPH045029B2 (enrdf_load_html_response) 1992-01-30
AT380256B (de) 1986-05-12
SE448543B (sv) 1987-03-02
AU8749382A (en) 1983-03-03
GEP19960641B (en) 1996-11-15
ES515176A0 (es) 1983-11-01
DE3231255C2 (enrdf_load_html_response) 1992-02-27
SU1447284A3 (ru) 1988-12-23

Similar Documents

Publication Publication Date Title
NO821886L (no) Bis-triazolderivat.
DK165695C (da) 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol
LV5511A3 (lv) Ú3H¾-imidazo-Ú5,1-a¾-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas panemiens
FI821696A0 (fi) Hydrodynamiskt smoerjsystem foer kolvanordningar, saerskilt foer stirling-motorer
FI822696A0 (fi) Sporthjaelm, saerskilt foer ishockey
IT8249295A0 (it) Composti di 1,4-diidropiridina
FI813461L (fi) Arbetsbord, speciellt foer hopsaettningsarbete
FI822452A0 (fi) Stockback, speciellt foer sportgevaer
DK267781A (da) 2,3-bis-hydroxybenzylderivater
DE3371781D1 (de) 1,4-methano-2-benzazepine derivatives
FI821091L (fi) Behaollare foer vaetskor, foeretraedesvis foer drycker
DK167182A (da) 5,6-o-isoalkylidenascorbinsyrederivater
GB2107317B (en) 20,21-dinoreburnamenine derivative
FI824279A0 (fi) 1,4-tiazinkarboxylsyraderivat, deras framstaellning och anvaendning och dessa derivat innehaollande blandningar
FI821046L (fi) Foerfarande foer framstaellning av -(3,4,5-trimetoxibenzoyltio)-propionylglycin
IT1152515B (it) 5-fenossifenil-tetraidro-1,3,5-tiadiazin-4-oni
DK264082A (da) 1,2,3,4,4a,9b-hexahydro-4a-piperazinylmethyl-4-dibenzofuranon dibenzofuranolderivater
KR880001629A (ko) 1,3,5-트리티안 유도체
DE3173762D1 (de) Thiazolinotriazine derivatives
FI824465A0 (fi) Vulkaniserbara, epoxider innehaollande etylenkopolymerer
BE890731A (nl) 2,4-dioxacyclohexanonderivaat
IT1189320B (it) 1-fenil-1,2,3-triazoli impiegabili come disappetenti
DE3269141D1 (de) Benzylazole derivatives
FI821125L (fi) Foerdelare foer smaeltor, isynnerhet mineralsmaeltor
TR21560A (tr) Etilsulfonilmetil-i,3 ogzazolidin herbisid antidot